MitoCareX Bio, a subsidiary of Nexentis Technologies, is enhancing its computational drug-discovery platform by expanding its bioinformatics capabilities to include disease-relevant biological pathway analysis. This development aims to integrate disease biology insights with existing protein structure and molecular interaction analyses, improving target evaluation and prioritization early in the drug discovery process. The company has added a bioinformatics expert to support this initiative and plans to incorporate these new capabilities alongside its current structural modeling and computational chemistry tools. This expansion is expected to broaden the scientific questions MitoCareX can address and strengthen the foundation for future drug discovery opportunities.
The story on Nexentis' MitoCareX Bio expanding computational biology capabilities is presented with Pluang's Health-sector market data for context. As of Oct 12, 2026 18:51 WIB, out of 128 priced Health-sector US stocks on Pluang, 64 rose and 43 fell. Among notable movers, Biogen Inc (BIIB) gained 3.39% to USD 233.37 with a typical hold time of 111 days, contrasting with Enveric Biosciences Inc (ENVB) which dropped 3.45% to USD 1.40 and Roivant Sciences Ltd. (ROIV) down 2.09% at USD 34.70, held typically for 14 and 3 days respectively.
Alignment Health Plan introduced Central Health Harmony, a new Medicare Advantage plan starting January 1, 2027, targeting Asian American seniors in Los Angeles and Orange counties. The plan offers access to over 600 physicians who speak Chinese, Kor...
NVIDIA and Cisco have introduced Ultra-Dense Small Form Factor Pluggable (USFP), a new optical module supporting 400Gb/s per lane, enabling up to 12.8Tb/s capacity for AI data centers. This technology doubles bandwidth per lane and increases power ef...
Hasbro announced the fourth annual Women Innovators of Play Design Challenge, accepting submissions from October 15 to November 20, 2026. The program now includes year-round in-person networking events alongside the design competition, aiming to conn...
Micas Networks introduced three new 102.4 Tbps open Ethernet switch platforms based on Broadcom Tomahawk 6 technology, designed to enhance AI factory networks. The portfolio includes air-cooled 800G, liquid-cooled 1.6T, and co-packaged optics (CPO) s...
Ferrari N.V. has repurchased 43,000 of its common shares on Euronext Milan as part of the third tranche of its multi-year €3.5 billion share buyback program announced in 2025. The recent purchases, totaling nearly €14.8 million, are part of a broader...
